Kevin co-founded the NIT with Dr. Rezai, after a distinguished career spanning over 20 years in venture capital and operating roles specializing in building medical device companies from concept to commercialization.Kevin brings an experienced and practiced hand to NIT, with roles spanning investment and board leadership, executive leadership, engineering, business development, and marketing.Prior to founding NIT, Kevin founded MentorCatalyst to pursue his passion for MedTech company-building and for working intimately with entrepreneurs with a craftsman-styled approach to working with startup MedTech teams, deeply engaging on a select few startup medical device companies, providing comprehensive leadership and guidance. Prior to NIT and MentorCatalyst, Kevin spent eleven years as a Managing Director at Versant Ventures where he focused on investing in and building early stage medical device companies, and participated in the Firms investments in over 100 healthcare companies across 3 different investment funds, with investment allocations of over $1.1 B in capital.Kevin currently serves, or has served, in board or advisory roles with companies which include Acclarent (acquired: Johnson & Johnson), Autonomic Technologies, Cereve, Eargo, LipoSonix (acquired: Medicis), Lutonix (acquired: Bard), Microfabrica, Neoguide Systems (acquired: Intuitive Surgical), Oculeve (acquired: Allergan), Respicardia, Rox Medical, Second Sight Medical (NASDAQ: EYES), St. Francis Medical (acquired: Kyphon), and The Innovation Factory.

Kevin previously held numerous operating leadership roles, including marketing and business development at Guidant Corporation, business development at Heartstream, and engineering development and management at Hughes Aircraft Company. Kevin holds both Bachelor's and Master's degrees in Mechanical Engineering, specializing in product design, as well as an MBA, all from Stanford University.

Continued here:

Team Neurotechnology Innovations Translator